Publications by authors named "Elisabeth Lindner"

Claim this Profile
T
Temporal action-effect prediction does not affect perceived loudness, but the sense of agency.
Elisabeth Lindner, Tobias Schöberl, Andrea Desantis, Alexander Gail

Conscious Cogn· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Violation of identity-specific action-effect prediction increases pupil size and attenuates auditory event-related potentials at P2 latencies when action-effects are behaviorally relevant.
Elisabeth Lindner, Andrea Desantis, Felicia Pei-Hsin Cheng, Alexander Gail

Neuroimage· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Gema Ariceta, Laure Collard, Saoussen Abroug, Shabbir H Moochhala, Edward Gould, Elisabeth Lindner

Pediatr Nephrol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
Bernd Hoppe, Patricia A Pellikka, Bastian Dehmel, Ana Banos, Elisabeth Lindner

Nephrol Dial Transplant· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studies.
Dawn S Milliner, Pierre Cochat, Sally-Anne Hulton, Jerome Harambat, Ana Banos, Elisabeth Lindner

Pediatr Nephrol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma oxalate: comparison of methodologies.
Felicity Stokes, Cecile Acquaviva-Bourdain, Bernd Hoppe, John C Lieske, Elisabeth Lindner

Urolithiasis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
Bernd Hoppe, Patrick Niaudet, Rémi Salomon, Jérôme Harambat, Sally-Anne Hulton, Elisabeth Lindner

Pediatr Nephrol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine oxalate biological variation in patients with primary hyperoxaluria.
Oliver Clifford-Mobley, Anna Sjögren, Elisabeth Lindner, Gill Rumsby

Urolithiasis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
Klaus Kaczirek, Tudor E Ciuleanu, Damir Vrbanec, Erika Marton, Diethelm Messinger, Elisabeth Lindner

Clin Colorectal Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG).
Zsuzsanna Kahán, Stanislav Spanik, Maria Wagnerova, Tomas Skacel, Barbara Planko, Elisabeth Lindner

Breast Cancer Res Treat· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis